Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a narrowing in their bile duct that doctors have not yet been able to identify the cause of
- People for whom a procedure called ERCP (a type of internal examination of the bile ducts) has been recommended by their doctor
Who may not be able to join:
- People in whom the ERCP procedure was unsuccessful, or where a bile sample could not be collected during the procedure
- People with serious existing health conditions
- People whose life expectancy is estimated at less than one year due to another illness
- People who are unlikely to follow the study plan, or who would be unable to attend follow-up visits
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yonghui Huang, Peking University Third Hospital
Phone: +86-13911765322
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Patient is diagnosed with malignant disease from biliary system
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.